Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer Cells
100%
MDA-MB-468
100%
Receptor Modulators
100%
Active Pharmaceutical Ingredients
100%
BT-474
100%
Aryl Hydrocarbon Receptor
100%
4-hydroxytamoxifen
25%
Mexiletine
25%
Tranilast
25%
Cytochrome P450 1A1 (CYP1A1)
16%
2,3,7,8-tetrachlorodibenzo-p-dioxin
16%
Breast Cancer Cell Lines
16%
Aryl Hydrocarbon
16%
Omeprazole
16%
Aryl Hydrocarbon Receptor Antagonist
16%
Sulindac
16%
Cell Context
16%
MDA-MB-468 Cells
16%
Leflunomide
16%
Highly Aggressive
8%
Receptor-interacting Protein Kinase 1 (RIPK1)
8%
Cell Migration
8%
Positive Control
8%
Receptor-mediated
8%
Agonist Activity
8%
Antagonist Activity
8%
Nimodipine
8%
Flutamide
8%
CYP1B1
8%
Cell Effects
8%
Structure Response
8%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Aromatic Hydrocarbon Receptor
100%
Receptor Agonist
21%
Afimoxifene
21%
Mexiletine
21%
Tranilast
21%
Messenger RNA
14%
2,3,7,8-Tetrachlorodibenzodioxin
14%
Cytochrome P450 1A1
14%
Omeprazole
14%
Receptor Antagonist
14%
Aromatic Hydrocarbon
14%
Sulindac
14%
Leflunomide
14%
Receptor Protein
7%
Flutamide
7%
CYP1B1
7%
Nimodipine
7%